Positron emission tomography (PET) and combined imaging modalities for staging lung cancer
WJ Scott - Surgical Clinics, 2002 - surgical.theclinics.com
Positron emission tomography (PET) and combined imaging modalities for staging lung cancer
- Surgical Clinics Skip to Main Content Advertisement Surgical Clinics Log in Register Log in …
- Surgical Clinics Skip to Main Content Advertisement Surgical Clinics Log in Register Log in …
Positron emission tomography in lung cancer
H Nomori, Y Ohba, K Yoshimoto, H Shibata… - General thoracic and …, 2009 - Springer
Recent advances in positron emission tomography (PET) with 2-deoxy-2-fluoro [F-18]-d-
glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the …
glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the …
Molecular imaging to improve radiotherapy
P Price - Radiotherapy and Oncology, 2006 - thegreenjournal.com
Molecular imaging is a hot topic and it is being increasingly used in the management of
patients undergoing radiotherapy. However, before being adopted into routine practice in …
patients undergoing radiotherapy. However, before being adopted into routine practice in …
Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006
F Vaylet, A Bonnichon, Y Salles, E Gontier… - … : Journal de la …, 2006 - europepmc.org
[Positron emission tomography using 18F-fluorodeoxyglucose in the management of
nonsmall cell lung cancers in 2006]. - Abstract - Europe PMC Sign in | Create an account …
nonsmall cell lung cancers in 2006]. - Abstract - Europe PMC Sign in | Create an account …
Low-sensitivity FDG-PET studies: less common lung neoplasms
JJ Erasmus, HA Macapinlac - Seminars in nuclear medicine, 2012 - Elsevier
Computed tomography (CT) and positron emission tomography (PET) using the
radiopharmaceutical 18F-2-deoxy-d-glucose (FDG) play an important role in the diagnosis …
radiopharmaceutical 18F-2-deoxy-d-glucose (FDG) play an important role in the diagnosis …
Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease
C Gámez-Cenzano, F Pino-Sorroche - PET clinics, 2014 - pet.theclinics.com
18F-fluorodeoxyglucose (FDG) is a glucose analog that accumulates preferentially in
malignant cells because of their higher glucose metabolism. PET/computed tomography …
malignant cells because of their higher glucose metabolism. PET/computed tomography …
[图书][B] Applications of FDG PET in Oncology: Best Clinical Practice
H Fujii, H Nakamura, S Yasuda - 2020 - books.google.com
This book provides up-to-date guidance on the use of FDG PET to assess the biological
activity and treatment response of a wide range of malignancies, including, for example …
activity and treatment response of a wide range of malignancies, including, for example …
The Heart or a Tumor?: Lung Cancer in the Lower Left Thorax Can Mimic Myocardial FDG Uptake on PET Imaging
F Ponzo, H Zhuang, C Woodfield… - Clinical nuclear …, 2003 - journals.lww.com
Positron emission tomography (PET) using the glucose analog F-18 fluorodeoxyglucose
(FDG) is a unique in vivo and noninvasive technique for assessing metabolism in tumor and …
(FDG) is a unique in vivo and noninvasive technique for assessing metabolism in tumor and …
Abstract SY42-02: Novel PET imaging in the clinic: Selecting patient cohorts and measuring early response
Molecular imaging with PET is most commonly associated with tumor detection and staging,
currently with [F-18]-fluorodeoxyglucose (FDG-PET) to measure energy metabolism …
currently with [F-18]-fluorodeoxyglucose (FDG-PET) to measure energy metabolism …